Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Connect Biopharma Holdings Ltd

NASDAQ: CNTB · Life Sciences · 4 alerts · CIK 1835268

Share price
$0.6430Close, Nov 16
Market cap
$41.5M
Shares outstanding
64.49MLatest SEC cover page
Sector
Life Sciences
Industry
Pharmaceutical PreparationsSIC 2834

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Connect Biopharma Holdings Ltd filings on SEC EDGAR ↗

7:05 AM ET 8-K
Clinical Trial Data

Connect Biopharma Holdings Clinical Trial Data

Connect Biopharma announced positive topline results from its global Phase 2 study of rademikibart as an add-on treatment for acute exacerbations in adults with COPD and type 2 inflammation. The study met its primary endpoint, with rademikibart reducing the rate of treatment failure by 81% and eliminating hospital readmissions or emergency department visits for new exacerbations through Week 4. The company plans to engage with the FDA to align on a Phase 3 registrational development program.

Earnings call
Sep 30, 2026, 8:00 AM ET

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.